Form D · Pharmaceuticals
ImmunoCellular Therapeutics, Ltd.
Montvale, NJ · CIK 0000822411
Offering snapshot reported Sep 12, 2022 · SEC filing
- Reported sold
- $750K Offering amount: $5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Aug 26, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 12, 2022 | Initial | $750,000 | No comparison | 1 | SEC filing |
| Mar 11, 2011 | Initial | $8,090,644 | No comparison | 41 | SEC filing |
| Jun 3, 2010 | Initial | $2,740,001 | No comparison | 12 | SEC filing |
| Apr 13, 2010 | Initial | $1,740,000 | No comparison | 18 | SEC filing |
| May 23, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 3, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 24, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 27, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 15, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 27, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-458604
Convertible Promissory Notes
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| None | None |
Source: Form D, filed Sep 12, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Bender | Executive |
| Jacqueline Brandwynne | Director |
| Richard A. Cowell | Director |
| Wayne Danson | Executive |
| Frank Douglas | Director |
| Eli Goldberger | Director, Executive |
| Navdeep Jaikaria | Director |
| Julie Kampf | Director |
| Robert Lehman | Director |
| Robert L. Martuza | Director |
| C. Kirk Peacock | Executive |
| Manish Singh | Director, Executive |
| Rahul Singhvi | Director |
| Irach Taraporewala | Director, Executive |
| John Yu | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
136 Summit Avenue
Montvale, NJ, 07645
Montvale, NJ, 07645